<?xml version="1.0" encoding="UTF-8"?>
<xml>
  <records>
    <record>
      <ref-type name="Journal Article">17</ref-type>
      <contributors>
        <authors>
          <author>F. Shi</author>
          <author>H. Tang</author>
          <author>W. Xie</author>
          <author>A. Anees</author>
          <author>Z. Yang</author>
          <author>X. Zhang</author>
        </authors>
      </contributors>
      <titles>
        <title>PHARMACOKINETIC STUDY OF ENROFLOXACIN IN TIANFU GEESE</title>
        <secondary-title>Journal of Animal and Plant Sciences</secondary-title>
        <alt-title>JAPS</alt-title>
      </titles>
      <dates><year>2014</year><pub-dates><date>2014/02/01</date></pub-dates></dates>
      <volume>24</volume>
      <number>1</number>
      <pages>113-119</pages>
      <isbn>1018-7081</isbn>
      <electronic-resource-num>NA</electronic-resource-num>
      <abstract>&lt;p&gt;The pharmacokinetic behavior of enrofloxacin (EF) was investigated in geese after oral (&lt;em&gt;p.o.&lt;/em&gt;) and intravenous (&lt;em&gt;i.v.&lt;/em&gt;) administrations of a single dose of 20 mg/kg body weight. Plasma concentrations of EF and its active metabolite, ciprofloxacin, were determined by high performance liquid chromatography fluorescence method. Plasma concentrations versus time were analyzed by non-compartmental method. The elimination half-life and area under drug concentration-time curve from zero to infinity of EF after&amp;nbsp;&lt;em&gt;i.v.&lt;/em&gt;&amp;nbsp;administration were 3.32 &amp;plusmn; 0.43 h and 45.73 &amp;plusmn; 5.74 mg/L&amp;middot;h, respectively. After&amp;nbsp;&lt;em&gt;p.o.&lt;/em&gt;&amp;nbsp;administration, EF was absorbed fast and the maximum plasma concentration of 3.86 &amp;plusmn; 0.36 mg/L reached at 2.14 &amp;plusmn; 1.10 h. The concentration-time profile of EF showed a double peak-shaped curve, indicating the possibility of enterohepatic recirculation of EF in geese. The bioavailability for EF after&amp;nbsp;&lt;em&gt;p.o.&lt;/em&gt;&amp;nbsp;administration was 78.09 &amp;plusmn; 25.76%. Seldom ciprofloxacin was detected in the plasma both after&amp;nbsp;&lt;em&gt;i.v.&lt;/em&gt;&amp;nbsp;and&amp;nbsp;&lt;em&gt;p.o.&lt;/em&gt;&amp;nbsp;administrations, indicating low transformation rate from EF to ciprofloxacin in geese. Taking into account the efficacy indices obtained, a single&amp;nbsp;&lt;em&gt;p.o.&lt;/em&gt; dose of 20 mg/kg of EF would be adequate for treating infections caused by highly susceptible bacteria in geese.&lt;/p&gt;</abstract>
      <keywords><keyword>pharmacokinetics; enrofloxacin; geese; intravenous administration; oral administration</keyword></keywords>
      <publisher>Pakistan Agricultural Scientists Forum</publisher>
      <urls><related-urls><url>https://thejaps.org.pk/AbstractView.aspx?mid=2014-JAPS-17</url></related-urls></urls>
    </record>
  </records>
</xml>
